- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- January 2025
- 123 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- August 2024
- 146 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- July 2024
- 136 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- May 2024
- 140 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 128 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 137 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 133 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- November 2024
- 180 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- December 2024
- 64 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Report
- October 2024
- 138 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- October 2024
- 237 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- October 2024
- 249 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- February 2025
- 185 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- April 2024
- 300 Pages
Global
From €4218EUR$4,450USD£3,524GBP
- Report
- December 2024
- 200 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- January 2025
- 99 Pages
Global
From €3313EUR$3,495USD£2,767GBP
- Report
- June 2024
Global
From €7109EUR$7,500USD£5,939GBP

The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more